cardiovascular-agents has been researched along with Postpartum-Hemorrhage* in 7 studies
7 other study(ies) available for cardiovascular-agents and Postpartum-Hemorrhage
Article | Year |
---|---|
Peripartum cardiomyopathy vs. sulprostone-associated heart failure? A case report and analysis of the literature.
Topics: Adult; Cardiomyopathy, Dilated; Cardiovascular Agents; Dinoprostone; Echocardiography; Female; Heart Failure; Humans; Peripartum Period; Postpartum Hemorrhage; Pregnancy; Pregnancy Complications, Cardiovascular; Puerperal Disorders; Treatment Outcome | 2013 |
Algorithm-based coagulation management of catastrophic amniotic fluid embolism.
Amniotic fluid embolism (AFE) is a rare, but often catastrophic, complication of pregnancy and associated with severe coagulopathy. We present an algorithm-based approach in managing coagulopathy and hemorrhage in a fatal case of histopathologically proven AFE. Thrombelastometry was used for rapid evaluation of the coagulation status. Stop of extensive hyperfibrinolysis with tranexamic acid, stabilization of initial clot formation with high-dose fibrinogen and platelet transfusions, and use of prothrombin complex concentrate together with a 1: 1 transfusion regimen of red packed cells and fresh frozen plasma was successful to control diffuse bleeding and restore clot firmness after hysterectomy. Stable clotting situation was maintained despite further clinical deterioration and development of multiple organ failure in this patient. Topics: Acidosis; Adult; Algorithms; Blood Coagulation Factors; Blood Component Transfusion; Cardiovascular Agents; Case Management; Catastrophic Illness; Combined Modality Therapy; Diagnosis, Differential; Drug Therapy, Combination; Embolism, Amniotic Fluid; Fatal Outcome; Female; Fibrinogen; Humans; Hypotension; Hysterectomy; Infant, Newborn; Male; Multiple Organ Failure; Placenta, Retained; Postpartum Hemorrhage; Pregnancy; Sperm Injections, Intracytoplasmic; Thrombelastography; Tranexamic Acid | 2010 |
[Use of gynofort in the prevention and therapy of early postpartum hemorrhage].
Topics: Cardiovascular Agents; Ergot Alkaloids; Female; Hemorrhage; Humans; Oxytocics; Postpartum Hemorrhage; Postpartum Period; Pregnancy | 1962 |
The third stage of labour.
Topics: Cardiovascular Agents; Ergot Alkaloids; Female; Hemorrhage; Humans; Hyaluronoglucosaminidase; Labor, Obstetric; Postpartum Hemorrhage; Postpartum Period; Pregnancy | 1961 |
[Directed methergine administration in prevention of postpartum hemorrhage].
Topics: Cardiovascular Agents; Ergot Alkaloids; Female; Hemorrhage; Humans; Labor, Obstetric; Methylergonovine; Oxytocics; Postpartum Hemorrhage; Pregnancy | 1957 |
Use of intravenous ergometrine to prevent postpartum haemorrhage.
Topics: Cardiovascular Agents; Ergonovine; Ergot Alkaloids; Female; Hemorrhage; Humans; Oxytocics; Postpartum Hemorrhage; Postpartum Period; Pregnancy | 1953 |
A management of postpartum hemorrhage by prolonged administration of oxytocics.
Topics: Cardiovascular Agents; Disease Management; Ergot Alkaloids; Female; Hemorrhage; Humans; Oxytocics; Oxytocin; Postpartum Hemorrhage; Postpartum Period; Pregnancy | 1952 |